|
|
Suppliers for
Pyrotinib
|
Properties | CAS |
1269662-73-8 |
|
2 Registered suppliers
Description : Pyrotinib, also known as SHR-1258, is a potent and selective EGFR/HER2 dual inhibitor with IC50s of 13 and 38 nM, respectively. Upon oral administration, pyrotinib binds to and inhibits both EGFR and HER2, which may result in the inhibition of tumor growth and angiogenesis, and tumor regression in EGFR/HER2-expressing tumor cells. Molecular Formula : C32H31ClN6O3 Canonical SMILES : CCOc1cc2c(cc1NC(=O)/C=C/[C@H]3CCCN3C)c(c(cn2)C#N)Nc4ccc(c(c4)Cl)OCc5ccccn5 InChI : 1S/C32H31ClN6O3/c1-3-41-30-17-27-25(16-28(30)38-31(40)12-10-24-8-6-14-39(24)2)32(21(18-34)19-36-27)37-22-9-11-29(26(33)15-22)42-20-23-7-4-5-13-35-23/h4-5,7,9-13,15-17,19,24H,3,6,8,14,20H2,1-2H3,(H,36,37)(H,38,40)/b12-10+/t24-/m1/s1 InChIKey : SADXACCFNXBCFY-IYNHSRRRSA-N Solubility : DMSO: 0.172 mg/mL Appearance : Light yellow to yellow solid Synonyms : (R,E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)acrylamide; Pyrotinib; SHR-1258; SHR1258; SHR 1258; Pyrotinib maleate
More details are to be found here
Detailed information on the suppliers of
Pyrotinib
|
Properties:
... more properties and specification on Pyrotinib
|
|
Privileged suppliers
Last update 2024-05-28
|